Novan, Inc. (NOVN) financial statements (2022 and earlier)
Company profile
| Business Address |
4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM, NC 27703 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 47,085 | 35,879 | 13,711 | 8,194 | 2,524 | 34,611 | ||
| Cash and cash equivalents | 47,085 | 35,879 | 13,711 | 8,194 | 2,524 | 34,611 | ||
| Prepaid expense | 1,697 | 1,818 | ||||||
| Deferred costs | 58 | 49 | 49 | 297 | ||||
| Disposal group, including discontinued operation | 114 | |||||||
| Other undisclosed current assets | 5,348 | 6,138 | 1,964 | 1,107 | 883 | 958 | ||
| Total current assets: | 54,130 | 44,007 | 15,724 | 9,350 | 3,704 | 35,569 | ||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 1,693 | 1,833 | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 12,201 | 2,406 | 10,506 | 15,868 | 16,624 | 16,290 | ||
| Intangible assets, net (including goodwill) | 75 | 75 | 75 | 75 | 75 | 75 | ||
| Intangible assets, net (excluding goodwill) | 75 | 75 | 75 | 75 | 75 | 75 | ||
| Restricted cash and investments | 583 | 540 | 539 | 539 | 539 | |||
| Other noncurrent assets | 278 | 341 | 419 | 530 | 192 | |||
| Total noncurrent assets: | 14,830 | 2,822 | 13,373 | 17,012 | 17,430 | 16,904 | ||
| TOTAL ASSETS: | 68,960 | 46,829 | 29,097 | 26,362 | 21,134 | 52,473 | ||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 6,964 | 3,315 | 3,208 | 4,086 | 4,851 | 7,630 | ||
| Accounts payable | 2,170 | 1,192 | 1,602 | 1,250 | 479 | 3,130 | ||
| Accrued liabilities | 3,251 | 969 | 1,169 | 1,369 | 2,204 | 2,195 | ||
| Employee-related liabilities | 1,543 | 1,154 | 437 | 1,467 | 2,168 | 2,305 | ||
| Deferred revenue | 2,586 | 2,990 | 4,428 | ✕ | ✕ | ✕ | ||
| Debt | 478 | 1,162 | 11 | 11 | 10 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 2,164 | |||
| Contract with customer, liability | ✕ | ✕ | ✕ | 4,401 | ✕ | ✕ | ||
| Other undisclosed current liabilities | 1,600 | 1,917 | 4,101 | 563 | 1,392 | 5,737 | ||
| Total current liabilities: | 11,150 | 8,700 | 12,899 | 9,061 | 8,418 | 13,377 | ||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 3,613 | 478 | 5,100 | 10 | 21 | 32 | ||
| Long-term debt, excluding current maturities | 478 | |||||||
| Capital lease obligations | ✕ | ✕ | ✕ | 10 | 21 | 32 | ||
| Operating lease, liability | 3,613 | 5,100 | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 10,736 | 9,025 | 7,654 | 4,095 | 6,919 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 6,919 | |||
| Deferred revenue | 10,665 | 8,238 | 7,076 | ✕ | ✕ | ✕ | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | 2,566 | ✕ | ✕ | ||
| Other liabilities | 71 | 787 | 578 | 289 | ||||
| Derivative instruments and hedges, liabilities | 1,240 | |||||||
| Other undisclosed noncurrent liabilities | 25,142 | 25,649 | 25,727 | 7,998 | 7,998 | 7,998 | ||
| Total noncurrent liabilities: | 39,491 | 35,152 | 38,481 | 12,103 | 14,938 | 8,030 | ||
| Total liabilities: | 50,641 | 43,852 | 51,380 | 21,164 | 23,356 | 21,407 | ||
| Stockholders' equity | ||||||||
| Stockholders' equity attributable to parent | 18,319 | 2,977 | (22,283) | 5,198 | (2,222) | 31,066 | ||
| Common stock | 2 | 14 | 3 | 3 | 2 | 2 | ||
| Treasury stock, value | (155) | (155) | (155) | (155) | (155) | (155) | ||
| Additional paid in capital | 297,441 | 252,395 | 197,853 | 177,677 | 158,091 | 154,252 | ||
| Accumulated deficit | (278,969) | (249,277) | (219,984) | (172,327) | (160,160) | (123,033) | ||
| Total stockholders' equity: | 18,319 | 2,977 | (22,283) | 5,198 | (2,222) | 31,066 | ||
| TOTAL LIABILITIES AND EQUITY: | 68,960 | 46,829 | 29,097 | 26,362 | 21,134 | 52,473 | ||
Income statement (P&L) ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 2,958 | 4,920 | 4,896 | 5,991 | 2,140 | ||
| Gross profit: | 2,958 | 4,920 | 4,896 | 5,991 | 2,140 | ||
| Operating expenses | (32,873) | (35,134) | (35,584) | (34,552) | (38,325) | (59,826) | |
| Operating loss: | (29,915) | (30,214) | (30,688) | (28,561) | (36,185) | (59,826) | |
| Nonoperating income (expense) | 223 | 921 | 311 | 15,888 | (942) | 127 | |
| Investment income, nonoperating | 81 | ||||||
| Other nonoperating income (expense) | (746) | 870 | 136 | 72 | 48 | ||
| Interest and debt expense | 956 | (2) | (1,047) | (2) | |||
| Net loss: | (28,736) | (29,293) | (30,379) | (13,720) | (37,127) | (59,701) | |
| Other undisclosed net income (loss) attributable to parent | (956) | 2 | 1,047 | 2 | |||
| Net loss available to common stockholders, diluted: | (29,692) | (29,293) | (30,377) | (12,673) | (37,127) | (59,699) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (28,736) | (29,293) | (30,379) | (13,720) | (37,127) | (59,701) | |
| Comprehensive loss: | (28,736) | (29,293) | (30,379) | (13,720) | (37,127) | (59,701) | |
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (956) | 2 | 1,047 | ||||
| Comprehensive loss, net of tax, attributable to parent: | (29,692) | (29,293) | (30,377) | (12,673) | (37,127) | (59,701) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.